<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161569">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02072395</url>
  </required_header>
  <id_info>
    <org_study_id>2012H0003</org_study_id>
    <nct_id>NCT02072395</nct_id>
  </id_info>
  <brief_title>Gastric Plication and Banding</brief_title>
  <acronym>GP and Band</acronym>
  <official_title>Treatment of Morbid Obesity With Gastric Plication and Gastric Banding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the efficacy of a hybrid laparoscopic surgical
      procedure for treatment of morbid obesity, Gastric Plication (G)) and Gastric Banding.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>Two years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary endpoint is weight loss two years post-surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Intra and post-operative complications will be tracked.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Morbid Obesity</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Plication</intervention_name>
    <description>Plication of the stomach will be performed in conjunction with placement of a gastric band.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70

          -  BMI &gt; or = to 30 and co-morbid conditions or BMI &gt; or = to 40

          -  Ability to provide informed consent

          -  Willingness to commit to long-term follow-up

        Exclusion Criteria:

          -  Inability to provide informed consent

          -  Presence of metabolic or medically correctable cause(s) for obesity, such as
             untreated hypothyroidism or Prader-Willi

          -  Contraindications to surgery such as myocardial infarction within last 6 months, end
             stage renal or liver disease, current infection, or other disease states
             contraindicative to surgery, in the principal investigator's opinion

          -  Pregnancy

          -  Plan to become pregnant within two years post-surgery

          -  Current addiction to drugs or alcohol

          -  Previous history of any type of bariatric surgery (de novo group only)

          -  Hiatal hernia &gt; 3 cm
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradley J Needleman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca Dettorre, MA</last_name>
    <phone>614-293-8549</phone>
    <email>becky.dettorre@osumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Dettorre, MA</last_name>
      <phone>614-293-8549</phone>
      <email>becky.dettorre@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley J Needleman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 24, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Bradley Needleman</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>morbid obesity</keyword>
  <keyword>bariatric surgery</keyword>
  <keyword>gastric banding</keyword>
  <keyword>gastric plication</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
